Searched for
PHARMEASY ACQUISITION
PharmEasy fails to raise Rs 1,000 crore equity, breaches covenant on Goldman Sachs loanPharmEasy was supposed to raise equity of around Rs 1,000 crore, or about $120 million, linked to its burn rate velocity. It has failed to ...
Exclusive | Not selling Thyrocare, will cut cash burn: PharmEasy founders to boardPharmEasy’s parent API Holdings has also delayed internal plans for a potential initial public offering (IPO) to 2025, the people privy to ...
PharmEasy delays IPO, targets Ebitda breakeven by next yearThe Mumbai-based firm is also stitching up a private financing round through a rights issue where company founders are expected to invest p...
Tata-owned 1mg, PharmEasy go offline for omnichannel presenceTata-owned 1mg is set to open its first physical store in Gurugram next month while rival PharmEasy has started to expand across the offlin...
PharmEasy parent API Holdings files papers for Rs 6,250 crore IPOAPI Holdings, the parent of online pharmacy PharmEasy, has filed its draft red herring prospectus (DRHP) with market regulator Sebi for a ₹...
PharmEasy parent to file DRHP soon for Rs 6,000-7,000 crore IPOThe IPO of PharmEasy’s parent API Holdings is expected to be a fully primary share sale. The e-pharmacy — India’s largest — aims to list be...
PharmEasy acquires Aknamed in $180-$190 million stock dealThe acquisition, which is similar to its purchase of Thyrocare in June, is part of the Mumbai-based company’s plans to position itself as a...
Thyrocare set for fast track with PharmEasyThyrocare is primarily a B2B diagnostic services provider. With PharmEasy’s presence, it will no longer be seen as a conventional diagnosti...
PharmEasy buyout puts Thyrocare in a different league: AnalystsThyrocare is making efforts to bolster its brand visibility through the opening of regional and zonal reference laboratories and branded co...
ETtech Exclusive: PharmEasy gets $300 million booster shot for Thyrocare dealPharmEasy has raised $300 million more, bringing the total funding received by the online pharmacy since April to $650 million, most of whi...
PharmEasy to acquire 66% stake in Thyrocare for over Rs 4,500 crorePharmEasy is acquiring a majority stake in diagnostics chain Thyrocare Technologies, in what the online pharmacy claimed was the first ever...
B Capital, Tiger Global eye PharmEasy stakeThe total size of the transaction could be about $40 million and may value the company at about $1.8 billion, up from the current $1.5 bill...
PharmEasy completes acquisition of MedlifeThe company has now become the largest healthcare delivery platform across the country, catering to more than two million families every si...
Prosus in talks to put $200 million into PharmEasyProsus is expected to get a double-digit stake in PharmEasy's parent. Private equity major TPG Capital is also picking up about 7% stake in...
PharmEasy in investment talks with Naspers, TPGOnline pharmacies such as PharmEasy and 1mg have registered growth outside their core metropolitan markets by rapidly expanding into tier-2...
Reliance retail acquires majority stake in Netmeds' parent for Rs 620 croreIn a late evening filing, RIL said that it will also get a 100% direct equity ownership of Netmeds' subsidiaries, Tresara Health, Netmeds M...
With RIL eyeing Netmeds deal, ePharmacy in for consolidationReliance's yet-to-be announced acquisition of Netmeds for an estimated $120 million is a catalyst for other players such as PharmEasy and M...